ANZCA Bulletin March 2014
Activated Charcoal Filters MHANZ statement
For information on the use of activated charcoal filters for malignant hyperthermia-susceptible patients read this article.
by Debon Dwyer
ANZCA Bulletin March 2014
For information on the use of activated charcoal filters for malignant hyperthermia-susceptible patients read this article.
by Debon Dwyer
This information is for the use of persons caring for potentially malignant hyperthermia susceptible individuals in a non-medical setting. (For example; child care, school or workplace).
Malignant Hyperthermia (malignant hyperpyrexia, MH) is a syndrome that can occur in susceptible people when they are given certain drugs only used in general anaesthetics and emergency medicine.
It occurs very rarely and is genetically inherited (it runs in the family). It is not transmissible.
It has little impact on a person’s health unless they are exposed to general anaesthetic agents – specifically all volatile anaesthetic agents (only administered in the hospital) and suxamethonium (only administered by trained paramedics and anaesthetic doctors).
Very rarely, people with MH can exhibit signs of exercise intolerance (with extreme exercise) or heat intolerance (with extreme heat) and these should be avoided if they cause distress.
If a person with MH is involved in an accident that requires emergency treatment, all paramedical and medical personnel should be informed of their MH status.
There are no specific actions required for most malignant hyperthermia susceptible persons. If the person indicates that they are susceptible to adverse effects of heat or exercise, precautions should be taken as above.
The requested URL /author/debon-dwyer/ was not found on this server.